Choi Hyo-Jick, Song Jae-Min, Bondy Brian J, Compans Richard W, Kang Sang-Moo, Prausnitz Mark R
School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, Georgia, United States of America; Department of Chemical and Materials Engineering, University of Alberta, Edmonton, Alberta, Canada.
Department of Global Medical Science, Sungshin Women's University, Seoul, Korea.
PLoS One. 2015 Jul 31;10(7):e0134431. doi: 10.1371/journal.pone.0134431. eCollection 2015.
Enveloped virus vaccines can be damaged by high osmotic strength solutions, such as those used to protect the vaccine antigen during drying, which contain high concentrations of sugars. We therefore studied shrinkage and activity loss of whole inactivated influenza virus in hyperosmotic solutions and used those findings to improve vaccine coating of microneedle patches for influenza vaccination. Using stopped-flow light scattering analysis, we found that the virus underwent an initial shrinkage on the order of 10% by volume within 5 s upon exposure to a hyperosmotic stress difference of 217 milliosmolarity. During this shrinkage, the virus envelope had very low osmotic water permeability (1 - 6×10-4 cm s-1) and high Arrhenius activation energy (Ea = 15.0 kcal mol-1), indicating that the water molecules diffused through the viral lipid membranes. After a quasi-stable state of approximately 20 s to 2 min, depending on the species and hypertonic osmotic strength difference of disaccharides, there was a second phase of viral shrinkage. At the highest osmotic strengths, this led to an undulating light scattering profile that appeared to be related to perturbation of the viral envelope resulting in loss of virus activity, as determined by in vitro hemagglutination measurements and in vivo immunogenicity studies in mice. Addition of carboxymethyl cellulose effectively prevented vaccine activity loss in vitro and in vivo, believed to be due to increasing the viscosity of concentrated sugar solution and thereby reducing osmotic stress during coating of microneedles. These results suggest that hyperosmotic solutions can cause biphasic shrinkage of whole inactivated influenza virus which can damage vaccine activity at high osmotic strength and that addition of a viscosity enhancer to the vaccine coating solution can prevent osmotically driven damage and thereby enable preparation of stable microneedle coating formulations for vaccination.
包膜病毒疫苗可能会被高渗透压溶液破坏,例如在干燥过程中用于保护疫苗抗原的溶液,这些溶液含有高浓度的糖类。因此,我们研究了全灭活流感病毒在高渗溶液中的收缩和活性丧失情况,并利用这些发现改进用于流感疫苗接种的微针贴片的疫苗包衣。通过停流光散射分析,我们发现病毒在暴露于217毫渗透压摩尔浓度的高渗应激差异后5秒内,体积最初收缩了约10%。在这种收缩过程中,病毒包膜具有非常低的渗透水渗透率(1 - 6×10-4厘米/秒)和高阿累尼乌斯活化能(Ea = 15.0千卡/摩尔),表明水分子通过病毒脂质膜扩散。在大约20秒到2分钟的准稳定状态后,根据二糖的种类和高渗渗透压差异,出现了病毒收缩的第二阶段。在最高渗透压下,这导致了起伏的光散射曲线,这似乎与病毒包膜的扰动有关,导致病毒活性丧失,这是通过体外血凝测量和小鼠体内免疫原性研究确定的。添加羧甲基纤维素有效地防止了疫苗在体外和体内的活性丧失,据信这是由于增加了浓缩糖溶液的粘度,从而在微针包衣过程中降低了渗透压应激。这些结果表明,高渗溶液可导致全灭活流感病毒发生双相收缩,在高渗透压下会损害疫苗活性,并且向疫苗包衣溶液中添加粘度增强剂可以防止渗透压驱动的损伤,从而能够制备用于疫苗接种的稳定微针包衣制剂。